These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 10423111

  • 1. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE.
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [Abstract] [Full Text] [Related]

  • 2. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [Abstract] [Full Text] [Related]

  • 3. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE.
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [Abstract] [Full Text] [Related]

  • 4. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G, MacIsaac RJ.
    Treat Endocrinol; 2002 Jul; 1(3):163-73. PubMed ID: 15799209
    [Abstract] [Full Text] [Related]

  • 5. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE.
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.
    Marshall SM.
    Diabet Med; 1999 May; 16(5):358-72. PubMed ID: 10342335
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R, Tonolo G.
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [Abstract] [Full Text] [Related]

  • 8. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL, Haria M, Wilde MI.
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [Abstract] [Full Text] [Related]

  • 9. [Risk and prevention of diabetic nephropathy].
    Ravera M, Re M, Deferrari G.
    G Ital Nefrol; 2007 Jun; 24 Suppl 38():13-9. PubMed ID: 17922442
    [Abstract] [Full Text] [Related]

  • 10. [Nephrology update. Kidney protection with antihypertensive drugs: I].
    Stein G, Fünfstück R, Sperschneider H, Ritz E.
    Med Klin (Munich); 2002 Sep 15; 97(9):541-6. PubMed ID: 12371082
    [Abstract] [Full Text] [Related]

  • 11. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr 15; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 12. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH.
    Diabetes Res Clin Pract; 1998 Apr 15; 39 Suppl():S43-7. PubMed ID: 9649959
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC, Atkins RC.
    Drugs; 2006 Apr 15; 66(17):2213-34. PubMed ID: 17137404
    [Abstract] [Full Text] [Related]

  • 14. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH.
    Diabetes Care; 1991 Mar 15; 14(3):260-9. PubMed ID: 2044441
    [Abstract] [Full Text] [Related]

  • 15. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec 15; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 16. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
    García-Donaire JA, Segura J, Cerezo C, Ruilope LM.
    Blood Press; 2011 Dec 15; 20(6):322-34. PubMed ID: 21936729
    [Abstract] [Full Text] [Related]

  • 17. Preventing end-stage renal disease.
    Mogensen CE.
    Diabet Med; 1998 Dec 15; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [Abstract] [Full Text] [Related]

  • 18. [Reduction of cardiovascular morbidity and mortality by combined antihypertensive drug therapy in patients with type 2 diabetes mellitus].
    Abrahamian H, Prager R.
    Wien Med Wochenschr; 2002 Dec 15; 152(9-10):210-4. PubMed ID: 12094390
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?
    Zanchetti A, Ruilope LM.
    J Hypertens; 2002 Nov 15; 20(11):2099-110. PubMed ID: 12409940
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effects of antihypertensive drugs.
    Preston RA.
    Am J Hypertens; 1999 Jan 15; 12(1 Pt 2):19S-32S. PubMed ID: 10077416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.